617 related articles for article (PubMed ID: 25961460)
1. MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids.
Fu X; Dong B; Tian Y; Lefebvre P; Meng Z; Wang X; Pattou F; Han W; Wang X; Lou F; Jove R; Staels B; Moore DD; Huang W
J Clin Invest; 2015 Jun; 125(6):2497-509. PubMed ID: 25961460
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of microRNA-125a contributes to obesity-associated insulin resistance and dysregulates lipid metabolism in mice.
Liu R; Wang M; Li E; Yang Y; Li J; Chen S; Shen WJ; Azhar S; Guo Z; Hu Z
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 May; 1865(5):158640. PubMed ID: 31988048
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic β cell microRNA-26a alleviates type 2 diabetes by improving peripheral insulin sensitivity and preserving β cell function.
Xu H; Du X; Xu J; Zhang Y; Tian Y; Liu G; Wang X; Ma M; Du W; Liu Y; Dai L; Huang W; Tong N; Wei Y; Fu X
PLoS Biol; 2020 Feb; 18(2):e3000603. PubMed ID: 32092075
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-26a-interleukin (IL)-6-IL-17 axis regulates the development of non-alcoholic fatty liver disease in a murine model.
He Q; Li F; Li J; Li R; Zhan G; Li G; Du W; Tan H
Clin Exp Immunol; 2017 Jan; 187(1):174-184. PubMed ID: 27377869
[TBL] [Abstract][Full Text] [Related]
6. RNA G-quadruplex regulates microRNA-26a biogenesis and function.
Liu G; Du W; Xu H; Sun Q; Tang D; Zou S; Zhang Y; Ma M; Zhang G; Du X; Ju S; Cheng W; Tian Y; Fu X
J Hepatol; 2020 Aug; 73(2):371-382. PubMed ID: 32165252
[TBL] [Abstract][Full Text] [Related]
7. MiR-130b promotes obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through alleviating M2 macrophage polarization via repression of PPAR-γ.
Zhang M; Zhou Z; Wang J; Li S
Immunol Lett; 2016 Dec; 180():1-8. PubMed ID: 27746169
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Inhibition of miR-33 Promotes Fatty Acid Oxidation but Does Not Ameliorate Metabolic Dysfunction in Diet-Induced Obesity.
Karunakaran D; Richards L; Geoffrion M; Barrette D; Gotfrit RJ; Harper ME; Rayner KJ
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2536-43. PubMed ID: 26427794
[TBL] [Abstract][Full Text] [Related]
9. Hepatic miR-125b inhibits insulin signaling pathway by targeting PIK3CD.
Du X; Li X; Chen L; Zhang M; Lei L; Gao W; Shi Z; Dong Y; Wang Z; Li X; Liu G
J Cell Physiol; 2018 Aug; 233(8):6052-6066. PubMed ID: 29319168
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of microRNA-26a protects against deficient β-cell function via targeting phosphatase with tensin homology in mouse models of type 2 diabetes.
Song Y; Jin D; Jiang X; Lv C; Zhu H
Biochem Biophys Res Commun; 2018 Jan; 495(1):1312-1316. PubMed ID: 29191656
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease.
Wang XC; Zhan XR; Li XY; Yu JJ; Liu XM
World J Gastroenterol; 2014 Dec; 20(47):17914-23. PubMed ID: 25548489
[TBL] [Abstract][Full Text] [Related]
12. Stress-activated
Calo N; Ramadori P; Sobolewski C; Romero Y; Maeder C; Fournier M; Rantakari P; Zhang FP; Poutanen M; Dufour JF; Humar B; Nef S; Foti M
Gut; 2016 Nov; 65(11):1871-1881. PubMed ID: 27222533
[TBL] [Abstract][Full Text] [Related]
13. miR-135a targets IRS2 and regulates insulin signaling and glucose uptake in the diabetic gastrocnemius skeletal muscle.
Agarwal P; Srivastava R; Srivastava AK; Ali S; Datta M
Biochim Biophys Acta; 2013 Aug; 1832(8):1294-303. PubMed ID: 23579070
[TBL] [Abstract][Full Text] [Related]
14. Elevated Hepatic miR-22-3p Expression Impairs Gluconeogenesis by Silencing the Wnt-Responsive Transcription Factor Tcf7.
Kaur K; Vig S; Srivastava R; Mishra A; Singh VP; Srivastava AK; Datta M
Diabetes; 2015 Nov; 64(11):3659-69. PubMed ID: 26193896
[TBL] [Abstract][Full Text] [Related]
15. Hepatic nitric oxide synthase 1 adaptor protein regulates glucose homeostasis and hepatic insulin sensitivity in obese mice depending on its PDZ binding domain.
Mu K; Sun Y; Zhao Y; Zhao T; Li Q; Zhang M; Li H; Zhang R; Hu C; Wang C; Jia W
EBioMedicine; 2019 Sep; 47():352-364. PubMed ID: 31473185
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-194 Modulates Glucose Metabolism and Its Skeletal Muscle Expression Is Reduced in Diabetes.
Latouche C; Natoli A; Reddy-Luthmoodoo M; Heywood SE; Armitage JA; Kingwell BA
PLoS One; 2016; 11(5):e0155108. PubMed ID: 27163678
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of MicroRNA-592 in obesity contributes to hyperglycemia and insulin resistance.
Song Y; Wu L; Li M; Xiong X; Fang Z; Zhou J; Yan G; Chen X; Yang J; Li Y
EBioMedicine; 2019 Apr; 42():494-503. PubMed ID: 30948354
[TBL] [Abstract][Full Text] [Related]
18. The microRNA-29 Family Dictates the Balance Between Homeostatic and Pathological Glucose Handling in Diabetes and Obesity.
Dooley J; Garcia-Perez JE; Sreenivasan J; Schlenner SM; Vangoitsenhoven R; Papadopoulou AS; Tian L; Schonefeldt S; Serneels L; Deroose C; Staats KA; Van der Schueren B; De Strooper B; McGuinness OP; Mathieu C; Liston A
Diabetes; 2016 Jan; 65(1):53-61. PubMed ID: 26696639
[TBL] [Abstract][Full Text] [Related]
19. An Endoplasmic Reticulum Stress-MicroRNA-26a Feedback Circuit in NAFLD.
Xu H; Tian Y; Tang D; Zou S; Liu G; Song J; Zhang G; Du X; Huang W; He B; Lin W; Jin L; Huang W; Yang J; Fu X
Hepatology; 2021 Apr; 73(4):1327-1345. PubMed ID: 32567701
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
